Mechanism of Action
Ginkgo biloba extract has two primary mechanisms relevant to brain health. First, it improves peripheral and cerebral blood flow by inhibiting platelet-activating factor and by producing vasodilatory effects in cerebral arteries, increasing oxygen and glucose delivery to brain tissue. Second, it has potent antioxidant activity through its flavonoid content, scavenging free radicals and reducing oxidative damage to neurons. Its terpenoid compounds, particularly ginkgolides, have anti-inflammatory properties and have been shown to reduce amyloid beta deposition in animal models of neurodegeneration.
Evidence Summary
Ginkgo biloba has been studied extensively in humans for dementia and age-related cognitive decline. Evidence is mixed: some large trials show modest benefit, others show no significant effect versus placebo on dementia progression. The most consistent evidence is for early cognitive decline and vascular dementia. In dogs specifically, research is limited. Ginkgo biloba extract has been included in veterinary cognitive dysfunction management protocols and is used by veterinarians in senior dog management. Petz Park positions Ginkgo as a cerebral circulation and neuroprotective support ingredient based on established mechanism and veterinary practice use, not on dog-specific clinical trial evidence.
In Petz Park Products
Brain Support for Dogs: Ginkgo Biloba Extract 90mg per scoop.
Safety and Considerations
Ginkgo biloba has antiplatelet properties and should not be used in animals on anticoagulant medications or scheduled for surgery without veterinary guidance. It should not be used in pregnant animals. At the doses used in Petz Park Brain Support it is generally well tolerated in dogs. Allow several weeks of consistent use before assessing effect.